Gilead Sciences
#6
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
2022 ESG Score
71.1
StrongStrong - Refers to a company that has achieved a reputation score within the 70–79-point range on a 0 – 100 scale. This is the second highest tier in our normative scale and is shown in light green.
- Poor 0-39
- Weak 40-59
- Average 60-69
- Strong 70-79
- Excellent 80+